Journal Rank: CiteScore 2.7 - Q3 (Oncology)
Median time to first editorial decision: 4 days

Journal of Cancer Metastasis and Treatment

This article systematically characterizes the role of ANKRD6 in COAD through pan-cancer analysis and GSVA, revealing its key regulatory signaling pathways. The findings deepen our understanding of ANKRD6 in COAD progression and highlight its potential as a novel therapeutic target.
By tracing how the liver's inherently tolerogenic environment, robust regenerative capacity, and lifelong antigen exposure interact with chronic injury, authors present a framework for distinguishing beneficial immunity from tumor-promoting inflammation.
Topic: Smart Nanomaterials for Cancer Immunotherapy;
Edited by Prof. Haijun Yu, Prof. Wujun Xu, Prof. Madiha Saeed, Prof. Weiqi Wang, Dr. Yi Lai
Exploring Innovative Multimodal and Individualized Strategies in Cervical Cancer Care: edited by Prof. Zhongqiu Lin, Prof. Qin Xu, and Prof. Huaiwu Lu.
On June 9, 2025, the editorial team had the great honor of interviewing a pioneer in ovarian cancer research - Prof. Robert C. Bast fromThe University of Texas MD Anderson Cancer Center.

Exclusive Interview with Prof. Akshay Sood

NaN

Submission Deadline: 31 Dec 2026

Published articles: 0

Lymph Node Metastasis: Crosstalk Mechanisms and Therapeutic Implications

Submission Deadline: 31 Aug 2026

Published articles: 0

Coming soon.

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/